TIDMMXF
RNS Number : 4751M
The MedicX Fund Limited
28 July 2017
Press Release
For immediate release
28 July 2017
MedicX Fund Limited
("MedicX Fund", "the Fund" or "the Company")
Board changes
MedicX Fund (LSE: MXF), the specialist primary care
infrastructure investor in modern, purpose-built, primary
healthcare properties in the United Kingdom and Ireland today
announces that the Board have approved two changes as part of its
succession planning and in readiness for the Company seeking to
convert to a UK REIT.
As announced on 15 March 2017, subject to shareholder approval
at an EGM, notice of which will be sent in the next few weeks, the
Company will seek entry into the UK REIT regime on 29 September
2017. Among certain other things, this will require the majority of
Board members to be UK resident from that date. Currently, the
majority of Board members are not UK resident.
The Board is therefore delighted to announce its intention,
subject to shareholder approval to seek to enter the UK REIT
regime, to appoint Laure Duhot, who is resident in the UK, to the
Board as a non-executive director with effect from 29 September
2017.
Laure currently acts for a number of property firms and
investors across Europe, providing strategic advice and transaction
support, with a focus on alternative real estate assets.
Up to the end of 2016, Laure was a managing director at Grainger
plc where she was responsible for fund management and corporate
finance for a number of fund vehicles operating in the UK and
Germany, among which was the GBP650 million GRIP REIT which she was
instrumental in setting-up in 2012 and which listed as a REIT in
2016.
Prior to her time at Grainger plc, Laure was a senior executive
with Pradera, and before that, with Sunrise Senior Living Inc, the
leading US senior living operator, where she was responsible for
international expansion playing a key role establishing the firm's
UK business. Laure has also acted as a non-executive director on a
number of company boards over the past 15 years, with current
mandates including MIC Limited and The Guinness Partnership, where
she is also a member of the Group Audit & Risk Committee.
The Company also re-confirms that, subject to shareholder
approval to seek to enter into the UK REIT regime, Shelagh Mason,
who is resident in Guernsey, will retire from the Board with effect
from 29 September 2017. The combination of Shelagh's retirement and
Laure's appointment will ensure that from 29 September 2017, the
majority of Board members will be UK resident.
David Staples, Chairman of MedicX Fund, commented:
"Although the appointment of Laure remains subject to
shareholder approval of the Company's intention to seek to enter
the UK REIT regime, we are delighted to welcome her to the Board.
Her experience and expertise in corporate development and strategic
finance, together with her experience of the UK REIT regime, will
be of great benefit to the Company and the Board as the Company
moves through a period of exciting change.
Although she still has two months left to serve, I would also
like to take this opportunity to thank Shelagh for her
extraordinary contribution both as a director and as a member of
the Audit Committee. Shelagh joined the Board at launch nearly
eleven years ago and has been invaluable to us throughout. We wish
her all the best in her other ventures."
End
For further information please contact:
MedicX Fund +44 (0) 1481 723 450
David Staples, Chairman
Octopus Healthcare Group +44 (0) 20 3142 4820
Mike Adams, Chief Executive Officer
Canaccord Genuity +44 (0) 20 7523 8000
Andrew Zychowski/Helen Goldsmith
Buchanan +44 (0) 20 7466 5000
Charles Ryland/Victoria Hayns
Information on MedicX Fund Limited
MedicX Fund Limited ("MXF", the "Fund" or the "Company", or
together with its subsidiaries, the "Group") is the specialist
primary care infrastructure investor in modern, purpose-built
primary healthcare properties in the United Kingdom, listed on the
London Stock Exchange, with a portfolio comprising 157
properties.
The Investment Adviser to the Company is Octopus Healthcare
Adviser Ltd, which is part of the Octopus Healthcare group. Octopus
Healthcare invests in and develops properties as well as creating
partnerships to deliver innovative healthcare buildings to improve
the health, wealth and wellbeing of the UK. It currently manages
over GBP1 billion of healthcare investments across a number of
platforms, with a focus on five core areas: GP surgeries, care
homes, special education schools, retirement housing and private
hospitals. Octopus Healthcare is part of the Octopus group, a
fast-growing UK fund management business with leading positions in
several specialist sectors including healthcare property, energy,
property finance and smaller company investing. Octopus manages
GBP6 billion of funds for more than 50,000 retail and institutional
investors.
Octopus Healthcare Adviser Ltd is authorised and regulated by
the Financial Conduct Authority.
The Company's website address is www.medicxfund.com. Neither the
contents of the Company's website nor the contents of any website
accessible from hyperlinks on the Company's website (or any other
website), nor the contents of any website accessible from
hyperlinks within this announcement, are incorporated into, or
forms part of, this announcement.
The Company's Legal Entity Identifier is
2138008POF35FTNFCB25.
This information is provided by RNS
The company news service from the London Stock Exchange
END
MSCOKFDQNBKDPOB
(END) Dow Jones Newswires
July 28, 2017 09:46 ET (13:46 GMT)
Medicx (LSE:MXF)
Historical Stock Chart
From Apr 2024 to May 2024
Medicx (LSE:MXF)
Historical Stock Chart
From May 2023 to May 2024